Bone morphogenetic protein-2 promotes survival and differentiation of striatal GABAergic neurons in the absence of glial cell proliferation

Journal of Neurochemistry

Volumn 72, Issue 6, 1999, Pages 2264-2271

  Hattori, Akira ^a,b   Katayama, Masahiro ^c,e   Iwasaki, Shoji ^a,d   Ishii, Kazuhiro ^c   Tsujimoto, Masafumi ^b   Kohno, Michiaki ^a,d  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bone morphogenetic protein 2; Neurotrophic factor; Striatal GABAergic neuron; Transforming growth factor superfamily

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; FLOXURIDINE; MICROTUBULE ASSOCIATED PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BONE REMODELING; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EMBRYO DEVELOPMENT; GABAERGIC TRANSMISSION; GLIA CELL; IMMUNOREACTIVITY; MOLECULAR CLONING; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; CORPUS STRIATUM; EMBRYO; FIBROBLAST GROWTH FACTOR 2; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033049146     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0722264.x     Document Type: Article

References (40)

1. Alexi T. and Hefti F. (1993) Trophic actions of transforming growth factor a on mesencephalic dopaminergic neurons developing in culture. Neuroscience 55, 903-918.
2. Carpenter M. B. and Sutin J. (1983) Human Neuroanatomy, Williams & Wilkins, Baltimore.
3. Celeste A. J., Iannazzi J. A., Taylor R. C., Hewick R. M., Rosen V., Wang E. A., and Wozney J. M. (1990) Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. USA 87, 9843-9847.
4. Engele J. and Bohn M. C. (1991) The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci. 11, 3070-3078.
5. Fallon J. H. and Loughlin S. E. (1985) Substantia nigra, in The Rat Nervous System, Vol. 1 (Paxinos G., ed), pp. 353-374. Academic Press, Sydney.
6. Graham A., Francis-West P., Brockell P., and Lumsden A. (1994) The signaling molecule BMP4 mediates apoptosis in the rhombencephalic neural crest. Nature 15, 684-686.
7. Graybiel A. M. and Ragsdale C. W. J. (1983) Biochemical anatomy of the striatum, in Chemical Neuroanatomy (Emson P. C., ed), pp. 427-504. Raven Press, New York.
8. Gross R. E., Mehler M. F., Mabie P. C., Zang Z., Santschi L., and Kessler J. A. (1996) Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 17, 595-606.
9. Heimer L., Alheid G. F., and Zaborszky L. (1985) Basal ganglia, in The Rat Nervous System, Vol. 1 (Paxinos G., ed), pp. 37-86. Academic Press, Sydney.
10. Hemmati-Brivanlou A. and Melton D. (1997) Vertebrate embryonic cells will become nerve cells unless told otherwise. Cell 88, 13-17.
11. Hogan B. L. M. (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10, 1580-1594.
12. Hou J.-G. G., Lin L.-F. H., and Mytilineou C. (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. J. Neurochem. 66, 74-82.
13. Ishida N., Tsujimoto M., Kanaya T., Shimamura A., Tsuruoka N., Kodama S., Katayama T., Oikawa S., Matsui M., Nakanishi T., Kobayashi J., and Nakazato H. (1994) Expression and characterization of human bone morphogenetic protein-2 in silkworm larvae infected with recombinant Bombyx mori nuclear polyhedrosis virus. J. Biochem. (Tokyo) 115, 279-285.
14. Ishii K., Inoue H., Hakura A., Araki W., and Masuda T. (1992) Immortalization of fetal mouse brain glial cells by human papillomavirus type 16 E7 genes. Cell Struct. Funct. 17, 197-202.
15. Iwasaki S., Tsuruoka N., Hattori A., Sato M., Tsujimoto M., and Kohno M. (1995) Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2. J. Biol. Chem. 270, 5476-5482.
16. Iwasaki S., Hattori A., Sato M., Tsujimoto M., and Kohno M. (1996) Characterization of the bone morphogenetic protein-2 as a neurotrophic factor: induction of neuronal differentiation of PC12 cells in the absence of mitogen-activated protein kinase activation. J. Biol. Chem. 271, 17360-17365.
17. Johansson B. M. and Wiles M. V. (1995) Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol. Cell. Biol. 15, 141-151.
18. Jones C. M., Lyons K. M., and Hogan B. L. M. (1991) Involvement of bone morphogenetic protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development 111, 531-542.
19. Jordan J., Bottner M., Schluesener H. J., Unsicker K., and Krieglstein K. (1997) Bone morphogenetic proteins: neurotrophic roles of midbrain dopaminergic neurons and implications of astroglial cells. Eur. J. Neurosci. 9, 1699-1710.
20. Kingsley D. M. (1994) The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8, 133-146.
21. Knüsel B., Michel P. P., Schwaber J., and Hefti F. (1990) Selective and non-selective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 10, 558-570.
22. Koeníg B. B., Cook J. S., Wolsing D. H., Ting J., Tiesman J. P., Correa P. E., Olson C. A., Pedquet A. L., Ventura F., Grant R. A., Chen G.-X., Warana J. L., Massague J., and Rosenbaum J. S. (1994) Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol. Cell. Biol. 14, 5961-5974.
23. Krieglstein K., Suter-Crazzolara C., Fisher W. H., and Unsicker K. (1995) TGF-β superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 14, 736-742.
24. Liu F., Ventura F., Doody J., and Massague J. (1995) Human type II receptor for bone morphogenetic proteins (BMPs): extension of two-kinase receptor model to the BMPs. Mol. Cell Biol. 15, 3479-3486.
25. Lyons K. M., Pelton R. W., and Hogan B. L. M. (1990) Organogenesis and pattern formation in the mouse; RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development 109, 833-844.
26. Mabie P. C., Mehler M. F., Marmur R., Papavasiliou A., Song Q., and Kessler J. A. (1997) Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial-astroglial progenitor cells. J. Neurosci. 17, 4112-4120.
27. Massague J. (1990) The transforming growth factor-β family. Annu. Rev. Cell Biol. 6, 597-641.
28. Mehler M. F., Mabie P. C., Zhang D., Kessler J. A. (1997) Bone morphogenetic proteins in the nervous system. Trends Neurosci. 20, 309-317.
29. Moses H. L. and Serra R. (1996) Regulation of differentiation by TGF-β. Curr. Opin. Genet. Dev. 6, 581-586.
30. Poulsen K. T., Armanini M, P., Klein R. D., Hynes A., Phillips H. S., and Rosenthal A. (1994) TGF-β2 and TGF-β3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13, 1245-1252.
31. Prehn J. H., Backhauss C., and Krieglstein J. (1993) Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical culture and protects mouse neocortex from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 13, 521-525.
32. Reiner A., Albin R. L., Anderson K. D., D'Amato C. J., Penney J. B., and Young A. (1988) Differential loss of striatal projection neurons in Huntington disease. Proc. Natl. Acad. Sci. USA 85, 5733-5737.
33. Rosenzweig B. L., Imamura T., Okadome T., Cox G. N., Yamashita H., ten Dijke P., Heldin C.-H., and Miyazono K. (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl. Acad. Sci. USA 92, 7632-7636.
34. Schluesener H. J. and Meyermann R. (1994) Expression of BMP-6, a TGF-β related morphogenetic cytokine, in rat radial glial cells. Glia 12, 161-164.
35. Shah N. M., Groves A. K., and Anderson D. J. (1996) Alternative neural crest cell fates are instructively promoted by TGF-β super-family members. Cell 85, 331-343.
36. Storm E. E., Huynh T. V., Copeland N. G., Jenkins N. A., Kingsley D., and Lee S.-J. (1994) Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily. Nature 368, 639-642.
37. Tomizawa K., Matsui H., Kondo E., Miyamoto K., Tokuda M., Itano T., Nagahata S., Akagi T., and Hatase O, (1995) Developmental alteration and neuron-specific expression of bone morphogenetic protein-6 (BMP-6) mRNA in rodent brain. Brain Res. Mol. Brain Res. 28, 122-128.
38. Ventimiglia R., Mather P. E., Jones B. E., and Lindsay R. M. (1995) The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur. J. Neurosci. 7, 213-222.
39. Widmer H. R. and Hefti F. (1994) Neurotrophin-4/5 promotes survival and differentiation of rat striatal neurons developing in culture. Eur. J. Neurosci. 6, 1669-1679.
40. Wozney J. M., Rosen V., Celeste A. J., Mitscock L. M., Whitters M. J., Kriz R. W., Hewick R. M., and Wang E. A. (1988) Novel regulators of bone formation: molecular cloning and activities. Science 242, 1528-1534.